Do a search on it at the top of your screen.
Ebola immunization is a tiny part of INO's business model.
Dr. Kim must not be connected politically well enough. Somehow he needs to get into these trials much earlier than he has done in the past. INO's generalized platform could very well be the best, but never make it unless pushed from the top.
Thanks for posting this.
Once we break through the key resistance at 0.63 this thing will run into the 0.70s fairly rapidly, IMHO. And even much higher depending on the PRs which come out in the coming weeks.
It could happen. Or the stop losses could be overwhelmed by even more new investors coming on board after learning about ONCS this week and having a day to digest more about the company and its future.
Either way, I'm primed with some dry powder to play with on Friday.
You've already backed off in this thread.
But that's right, your attention span is pretty short.
Alright, I've done burning worthless bandwidth with you. You're simply not worth my time. Smarter people are worth my time. Post some intelligent things about INO and ONCS and you may someday be redeemed. But I doubt that will ever happen because you've got an agenda, an insecurity, or likely both.
Carry on, and seek the help that you need.
0.63 is the next key resistance level. It's been a tough wall to break down for a long time.
But once we break through it I believe the 0.70s will come fairly quickly.
We may need a good PR to bust through, though. Go ONCS!
Scared you, didn't I. Ever hear of counter lawsuits?
Go back to school and come back when you believe you can take on someone your own size. You're way out of your league here, little fella...
Your alias and your limited vocabulary speak legions about you. Who are people going to believe? Some uneducated person such as yourself? Someone who know NOTHING about ONCS?
This board is for smart investors only. Move along.
I'm afluvu's bodyguard. You have to deal with me first. LMAO!
You're simply a mindless jerk with limited English language skills.
Your alias and limited vocabulary speak legions about you. Who are smart people going to believe? You or me?
Consider yourself "pumped and dumped."
Do our due diligence. INO is at least 2-3 years behind ONCS bringing a product to market for melanoma.
ONCS has changed its business model within the last 6 months. They will no longer be solely focusing on melanoma, but expanding to other indications as their science is proved out. Thus, their pipeline may become just as large as INO's over time...
Fair enough. I'll take it like a man. :)
I should have written something like "with the loss of one of the two Roche deals..."
Thanks for bringing this to my attention...